Time to act on injectable-free regimens for children with multidrug-resistant tuberculosis

Lancet Respir Med. 2018 Sep;6(9):662-664. doi: 10.1016/S2213-2600(18)30329-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Child
  • Diarylquinolines
  • Humans
  • Retrospective Studies
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Diarylquinolines
  • bedaquiline